{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:33:41Z","timestamp":1792492421007,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["TTACC0422TT"],"award-info":[{"award-number":["TTACC0422TT"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60073-0","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T08:52:18Z","timestamp":1747990338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Enhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytes"],"prefix":"10.1038","volume":"16","author":[{"given":"Cesare","family":"Canepari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-678X","authenticated-orcid":false,"given":"Michela","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0138-2197","authenticated-orcid":false,"given":"Chiara","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Starinieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-9900","authenticated-orcid":false,"given":"Monica","family":"Volpin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7604-6967","authenticated-orcid":false,"given":"Anna","family":"Fabiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-2854","authenticated-orcid":false,"given":"Mauro","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Norata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Brombin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cugnata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1771-6067","authenticated-orcid":false,"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4046-8420","authenticated-orcid":false,"given":"Francesca","family":"Sanvito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-4345","authenticated-orcid":false,"given":"Markus","family":"Grompe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-997X","authenticated-orcid":false,"given":"Alessio","family":"Cantore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"60073_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41575-022-00729-0","volume":"20","author":"N Zabaleta","year":"2023","unstructured":"Zabaleta, N., Unzu, C., Weber, N. D. & Gonzalez-Aseguinolaza, G. Gene therapy for liver diseases - progress and challenges. Nat. Rev. Gastroenterol. Hepatol. 20, 288\u2013305 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"60073_CR2","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1056\/NEJMoa2211075","volume":"388","author":"J Mahlangu","year":"2023","unstructured":"Mahlangu, J. et al. Two-year outcomes of valoctocogene roxaparvovec therapy for hemophilia A. N. Engl. J. Med 388, 694\u2013705 (2023).","journal-title":"N. Engl. J. Med"},{"key":"60073_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1056\/NEJMoa2211644","volume":"388","author":"SW Pipe","year":"2023","unstructured":"Pipe, S. W. et al. Gene therapy with etranacogene dezaparvovec for hemophilia B. N. Engl. J. Med 388, 706\u2013718 (2023).","journal-title":"N. Engl. J. Med"},{"key":"60073_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","volume":"11","author":"G Ronzitti","year":"2020","unstructured":"Ronzitti, G., Gross, D. A. & Mingozzi, F. Human immune responses to adeno-associated virus (AAV) vectors. Front Immunol. 11, 670 (2020).","journal-title":"Front Immunol."},{"key":"60073_CR5","doi-asserted-by":"publisher","first-page":"277ra228","DOI":"10.1126\/scitranslmed.aaa1405","volume":"7","author":"A Cantore","year":"2015","unstructured":"Cantore, A. et al. Liver-directed lentiviral gene therapy in a dog model of hemophilia B. Sci. Transl. Med 7, 277ra228 (2015).","journal-title":"Sci. Transl. Med"},{"key":"60073_CR6","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1093\/hmg\/ddu746","volume":"24","author":"J Clar","year":"2015","unstructured":"Clar, J. et al. Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice. Hum. Mol. Genet 24, 2287\u20132296 (2015).","journal-title":"Hum. Mol. Genet"},{"key":"60073_CR7","doi-asserted-by":"crossref","unstructured":"Milani, M. et al. Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates. Sci. Transl. Med. 11, eaav7325 (2019).","DOI":"10.1126\/scitranslmed.aav7325"},{"key":"60073_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30102-3","volume":"13","author":"M Milani","year":"2022","unstructured":"Milani, M. et al. Liver-directed lentiviral gene therapy corrects hemophilia A mice and achieves normal-range factor VIII activity in non-human primates. Nat. Commun. 13, 2454 (2022).","journal-title":"Nat. Commun."},{"key":"60073_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32576-7","volume":"13","author":"CT Nicolas","year":"2022","unstructured":"Nicolas, C. T. et al. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions. Nat. Commun. 13, 5012 (2022).","journal-title":"Nat. Commun."},{"key":"60073_CR10","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1016\/j.ymthe.2022.10.004","volume":"30","author":"A Kapelanski-Lamoureux","year":"2022","unstructured":"Kapelanski-Lamoureux, A. et al. Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma. Mol. Ther. 30, 3542\u20133551 (2022).","journal-title":"Mol. Ther."},{"key":"60073_CR11","doi-asserted-by":"crossref","unstructured":"Vonada, A. et al. Therapeutic liver repopulation by transient acetaminophen selection of gene-modified hepatocytes. Sci. Transl. Med. 13, eabg3047 (2021).","DOI":"10.1126\/scitranslmed.abg3047"},{"key":"60073_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1097\/HEP.0000000000000631","volume":"79","author":"A Vonada","year":"2024","unstructured":"Vonada, A. et al. Complete correction of murine phenylketonuria by selection-enhanced hepatocyte transplantation. Hepatology 79, 1088\u20131097 (2024).","journal-title":"Hepatology"},{"key":"60073_CR13","first-page":"131","volume":"4","author":"E Yoon","year":"2016","unstructured":"Yoon, E., Babar, A., Choudhary, M., Kutner, M. & Pyrsopoulos, N. Acetaminophen-induced hepatotoxicity: a comprehensive update. J. Clin. Transl. Hepatol. 4, 131\u2013142 (2016).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"60073_CR14","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1182\/blood-2005-10-4047","volume":"107","author":"FR Santoni de Sio","year":"2006","unstructured":"Santoni de Sio, F. R., Cascio, P., Zingale, A., Gasparini, M. & Naldini, L. Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction. Blood 107, 4257\u20134265 (2006).","journal-title":"Blood"},{"key":"60073_CR15","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1182\/blood-2006-10-049312","volume":"109","author":"BD Brown","year":"2007","unstructured":"Brown, B. D. et al. In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109, 2797\u20132805 (2007).","journal-title":"Blood"},{"key":"60073_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/hep.29176","volume":"66","author":"M Hosel","year":"2017","unstructured":"Hosel, M. et al. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors. Hepatology 66, 252\u2013265 (2017).","journal-title":"Hepatology"},{"key":"60073_CR17","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1182\/blood-2007-03-078493","volume":"110","author":"BD Brown","year":"2007","unstructured":"Brown, B. D. et al. A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 110, 4144\u20134152 (2007).","journal-title":"Blood"},{"key":"60073_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.tranon.2014.07.002","volume":"7","author":"I Mlynarczuk-Bialy","year":"2014","unstructured":"Mlynarczuk-Bialy, I. et al. Biodistribution and efficacy studies of the proteasome inhibitor BSc2118 in a mouse melanoma model. Transl. Oncol. 7, 570\u2013579 (2014).","journal-title":"Transl. Oncol."},{"key":"60073_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1160\/TH05-08-0559","volume":"95","author":"WS Bril","year":"2006","unstructured":"Bril, W. S. et al. Tolerance to factor VIII in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution. Thromb. Haemost. 95, 341\u2013347 (2006).","journal-title":"Thromb. Haemost."},{"key":"60073_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4110\/in.2012.12.3.126","volume":"12","author":"Y Kim","year":"2012","unstructured":"Kim, Y. et al. A case of drug-induced hepatitis due to bortezomib in multiple myeloma. Immune Netw. 12, 126\u2013128 (2012).","journal-title":"Immune Netw."},{"key":"60073_CR21","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/mt.2012.150","volume":"20","author":"J Agudo","year":"2012","unstructured":"Agudo, J. et al. A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade. Mol. Ther. 20, 2257\u20132267 (2012).","journal-title":"Mol. Ther."},{"key":"60073_CR22","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1073\/pnas.1214441110","volume":"110","author":"D Finkelshtein","year":"2013","unstructured":"Finkelshtein, D., Werman, A., Novick, D., Barak, S. & Rubinstein, M. LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus. Proc. Natl. Acad. Sci. USA 110, 7306\u20137311 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60073_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03432-4","volume":"9","author":"J Nikolic","year":"2018","unstructured":"Nikolic, J. et al. Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein. Nat. Commun. 9, 1029 (2018).","journal-title":"Nat. Commun."},{"key":"60073_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ni1527","volume":"8","author":"K Takenaka","year":"2007","unstructured":"Takenaka, K. et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat. Immunol. 8, 1313\u20131323 (2007).","journal-title":"Nat. Immunol."},{"key":"60073_CR25","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s44321-024-00072-8","volume":"16","author":"M Milani","year":"2024","unstructured":"Milani, M. et al. GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice. EMBO Mol. Med. 16, 1427\u20131450 (2024).","journal-title":"EMBO Mol. Med."},{"key":"60073_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1182\/blood-2010-05-284737","volume":"117","author":"M Hirai","year":"2011","unstructured":"Hirai, M. et al. Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis. Blood 117, 500\u2013509 (2011).","journal-title":"Blood"},{"key":"60073_CR27","first-page":"135","volume":"8","author":"L Raedler","year":"2015","unstructured":"Raedler, L. Velcade (bortezomib) receives 2 new FDA indications: for retreatment of patients with multiple myeloma and for first-line treatment of patients with mantle-cell lymphoma. Am. Health Drug Benefits 8, 135\u2013140 (2015).","journal-title":"Am. Health Drug Benefits"},{"key":"60073_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/acr2.11414","volume":"4","author":"MF Loncharich","year":"2022","unstructured":"Loncharich, M. F. & Anderson, C. W. Interferon inhibition for lupus with anifrolumab: critical appraisal of the evidence leading to FDA approval. ACR Open Rheumatol. 4, 486\u2013491 (2022).","journal-title":"ACR Open Rheumatol."},{"key":"60073_CR29","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1194\/jlr.P009860","volume":"51","author":"JD Browning","year":"2010","unstructured":"Browning, J. D. & Horton, J. D. Fasting reduces plasma proprotein convertase, subtilisin\/kexin type 9 and cholesterol biosynthesis in humans. J. Lipid Res. 51, 3359\u20133363 (2010).","journal-title":"J. Lipid Res."},{"key":"60073_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","volume":"382","author":"EF Morand","year":"2020","unstructured":"Morand, E. F. et al. Trial of anifrolumab in active systemic lupus erythematosus. N. Engl. J. Med 382, 211\u2013221 (2020).","journal-title":"N. Engl. J. Med"},{"key":"60073_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/toxsci\/kfn093","volume":"104","author":"LM Aleksunes","year":"2008","unstructured":"Aleksunes, L. M., Campion, S. N., Goedken, M. J. & Manautou, J. E. Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. Toxicol. Sci. 104, 261\u2013273 (2008).","journal-title":"Toxicol. Sci."},{"key":"60073_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.510290241","volume":"29","author":"RM Shayiq","year":"1999","unstructured":"Shayiq, R. M. et al. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. Hepatology 29, 451\u2013463 (1999).","journal-title":"Hepatology"},{"key":"60073_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2018.04.012","volume":"342","author":"A Annoni","year":"2019","unstructured":"Annoni, A., Gregori, S., Naldini, L. & Cantore, A. Modulation of immune responses in lentiviral vector-mediated gene transfer. Cell Immunol. 342, 103802 (2019).","journal-title":"Cell Immunol."},{"key":"60073_CR34","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/hep.24230","volume":"53","author":"J Matrai","year":"2011","unstructured":"Matrai, J. et al. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology 53, 1696\u20131707 (2011).","journal-title":"Hepatology"},{"key":"60073_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57383-8","volume":"16","author":"C Simoni","year":"2025","unstructured":"Simoni, C. et al. Liver fibrosis negatively impacts in vivo gene transfer to murine hepatocytes. Nat. Commun. 16, 2119 (2025).","journal-title":"Nat. Commun."},{"key":"60073_CR36","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41591-021-01389-4","volume":"27","author":"D Cesana","year":"2021","unstructured":"Cesana, D. et al. Retrieval of vector integration sites from cell-free DNA. Nat. Med. 27, 1458\u20131470 (2021).","journal-title":"Nat. Med."},{"key":"60073_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1937-9","volume":"18","author":"G Spinozzi","year":"2017","unstructured":"Spinozzi, G. et al. VISPA2: a scalable pipeline for high-throughput identification and annotation of vector integration sites. BMC Bioinforma. 18, 520 (2017).","journal-title":"BMC Bioinforma."},{"key":"60073_CR38","doi-asserted-by":"crossref","unstructured":"Pais, G. et al. ISAnalytics enables longitudinal and high-throughput clonal tracking studies in hematopoietic stem cell gene therapy applications. Brief Bioinform. 24, bbac5511 (2023).","DOI":"10.1093\/bib\/bbac551"},{"key":"60073_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/bioinformatics\/bts004","volume":"28","author":"CC Berry","year":"2012","unstructured":"Berry, C. C. et al. Estimating abundances of retroviral insertion sites from DNA fragment length data. Bioinformatics 28, 755\u2013762 (2012).","journal-title":"Bioinformatics"},{"key":"60073_CR40","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","volume":"117","author":"A Biffi","year":"2011","unstructured":"Biffi, A. et al. Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 117, 5332\u20135339 (2011).","journal-title":"Blood"},{"key":"60073_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1538-7836.2009.03717.x","volume":"8","author":"M Franchini","year":"2010","unstructured":"Franchini, M., Favaloro, E. J. & Lippi, G. Mild hemophilia A. J. Thromb. Haemost. 8, 421\u2013432 (2010).","journal-title":"J. Thromb. Haemost."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60073-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T08:52:22Z","timestamp":1747990342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60073-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60073"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60073-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.C. and A.C. are inventors on patent applications submitted by Fondazione Telethon, San Raffaele Scientific Institute, on LV technology related to the work presented in this manuscript. Fondazione Telethon and San Raffaele Scientific Institute, through SR-Tiget, have established a research collaboration on liver-directed LV gene therapy of hemophilia with GeneSpire. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4802"}}